The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of SeaStar Medical Holding Corp (NASDAQ: ICU) was $0.23 for the day, down -1.85% from the previous closing price of $0.23. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 0.48 million shares were traded. ICU stock price reached its highest trading level at $0.2324 during the session, while it also had its lowest trading level at $0.225.
Ratios:
Our analysis of ICU’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 ’25 when Baird Jennifer A bought 4,200 shares for $0.24 per share. The transaction valued at 987 led to the insider holds 36,200 shares of the business.
Messinger Michael bought 14,500 shares of ICU for $5,098 on Dec 09 ’25. The Chief Financial Officer now owns 17,500 shares after completing the transaction at $0.35 per share. On Aug 26 ’25, another insider, Van Heel Kenneth, who serves as the Director of the company, bought 25,000 shares for $0.89 each. As a result, the insider paid 22,248 and bolstered with 39,400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICU now has a Market Capitalization of 7773984 and an Enterprise Value of -5544253. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.34 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at -6.293.
Stock Price History:
The Beta on a monthly basis for ICU is -1.00, which has changed by -0.8810257 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, ICU has reached a high of $3.07, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -42.87%, while the 200-Day Moving Average is calculated to be -73.47%.
Shares Statistics:
ICU traded an average of 2.05M shares per day over the past three months and 1348850 shares per day over the past ten days. A total of 36.05M shares are outstanding, with a floating share count of 35.77M. Insiders hold about 0.76% of the company’s shares, while institutions hold 3.03% stake in the company. Shares short for ICU as of 1765756800 were 1010331 with a Short Ratio of 0.49, compared to 1763078400 on 399709. Therefore, it implies a Short% of Shares Outstanding of 1010331 and a Short% of Float of 2.8199999.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11. Analysts are recommending an EPS of between -$0.63 and -$0.63 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.44, with 1.0 analysts recommending between -$0.44 and -$0.44.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 1 analysts. It ranges from a high estimate of $245k to a low estimate of $245k. As of. The current estimate, SeaStar Medical Holding Corp’s year-ago sales were $67kFor the next quarter, 1 analysts are estimating revenue of $375k. There is a high estimate of $375k for the next quarter, whereas the lowest estimate is $375k.
A total of 1 analysts have provided revenue estimates for ICU’s current fiscal year. The highest revenue estimate was $1.06M, while the lowest revenue estimate was $1.06M, resulting in an average revenue estimate of $1.06M. In the same quarter a year ago, actual revenue was $135kBased on 1 analysts’ estimates, the company’s revenue will be $1.74M in the next fiscal year. The high estimate is $1.74M and the low estimate is $1.74M.
